Xie, K., Yang, H., Leng, W., Liu, C., Yang, Y., Wang, X., Cao, D., Wu, H., Bi, F. (2026). QL1706 (PD-1/CTLA-4 bispecific antibody) plus bevacizumab specific for patients with hepatocellular carcinoma combined with lung metastasis: A secondary analysis of a prospective, single-arm, phase Ib/II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4114